Anti-idiotypic antibodies have been raised against antibodies to retinol-binding protein (RBP) and to insulin. After absorption the anti-idiotypic antibodies recognized the antigen-combining sites of the antibodies used as the immunogen but of no other antibodies. Some of the anti-idiotypic antibodies raised against antibodies to RBP bound specificanly to rat intestine epithelial cells, which have a physiological cell-surface receptor for RBP. The RBP receptor mediates the uptake of retinol from RBP to the cells. This uptake was abolished in a concentration-dependent manner by the anti-idiotypic antibodies, which obviously competed with RBP for binding to the receptor.
MATERIALS AND METHODS Antisera. The antiserum against jB2-microglobulin was the same as that used earlier (4) . A rabbit antiserum was raised against highly purified, papain-solubilized rat transplantation (Ag-B) antigens.* Sprague-Dawley rats were immunized with bovine insulin by a described procedure (5) . After several booster injections the rats were exsanguinated and the serum was collected from 10 animals. Specific antibodies against insulin were isolated by immunosorbent purification on a Sepharose-4B column to which insulin had been covalently attached (6) . The pooled rat antibodies to insulin in Freund's complete adjuvant were injected into two rabbits which were boosted with the antigen in Freund's incomplete adjuvant three times on alternate weeks. Preimmune sera were obtained from the rabbits and were used as control sera throughout. The immunization schedule for obtaining anti-idiotypic antiserum against antibodies to RBP was identical to that described earlier (7) .
IgG fractions from the anti-idiotypic antisera were isolated by affinity chromatography on Sepharose-4B columns containing covalently bound Staphylocccus aureus protein A (8) .
To remove antibodies directed against common determinants on rat IgG we subjected the anti-idiotypic IgG fractions to immunosorbent chromatography on Sepharose-4B columns containing covalently bound rat IgG. The rat IgG used in each case was isolated by protein A column affinity chromatography from the breakthrough fractions obtained after immunosorbent purification of the rat antisera (see above). In this way we ascertained that antibodies in the anti-idiotypic IgG fractions directed against subgroup-specific rat IgG antigenic determinants were removed. IgG fractions from the preimmune sera of the rabbits were processed in an identical fashion.
Prior to use the anti-idiotypic IgG fractions were passed over affinity chromatography columns containing covalently bound insulin and RBP to eliminate possible antibodies that might react directly with the proteins. The IgG in the breakthrough fractions of the columns were finally subjected to gel chromatography on columns of Sephadex G-200 to eliminate possible traces of protein that may have leaked from the affinity chromatography columns. The IgG fractions did not contain measurable amounts of insulin or RBP, as determined by sensitive radioimmunoassay procedures (4) .
Radioactive Labeling of Proteins. Bovine insulin (Sigma Chemical Co.) was labeled with 1251 as described (9) . The regular chloramin-T procedure for iodine labeling was used in all other cases (10) .
[3H]Retinol (New England Nuclear, Dreieichenhein, Germany) was introduced into RBP as reported elsewhere (11) .
Measurements of IgG Binding and [3HJRetinol Uptake by Intestine Epithelial Cells. Intestine epithelial cells were isolated from Sprague-Dawley rats essentially as described (11 (17) . RBP was purified from human serum (18) .
RESULTS
The rationale behind the experiments is schematically depicted in Fig. 1 antibodies should be present in the D' and E' subsets. As a consequence, C' anti-idiotypic antibodies and ligand B will compete for the same site on receptor A and exhibit mutually exclusive binding.
Specificity of Anti-Idiotypic Antibodies. Fab and Fc fragments were isolated from the specific rat antibodies against insulin and RBP. Mixtures of the two types of Fab fragments, labeled with 125I and 1311, respectively, were separately incubated with each one of the anti-idiotypic IgG fractions and subjected to gel chromatography on columns (100 X 1 cm) of Sephadex G-200 equilibrated with 20 mM TrisHCl, pH 8 .0/0.15 M NaCl. When the mixtures contained anti-idiotypic antibodies raised against antibodies to insulinno Fab fragments against RBP bound to the anti-idiotypic antibodies since all of the 125I radioactivity was found at the elution position typical for free Fab fragments. In contrast, most of the Fab fragments against insulin bound to the anti-idiotypic antibodies since more than 80% of the 131I radioactivity emerged close to the void fraction. The radioactive Fab fragments against RBP and insulin displayed the reciprocal elution behavior when the antiidiotypic IgG fraction was directed against the antibodies to RBP. Control experiments showed that neither of the antiidiotypic IgG fractions reacted with 125I-labeled Fc fragments. IgG from the preimmune rabbit sera did not react with the labeled Fab fragments directed against insulin and RBP. These results indicate that the anti-idiotypic IgG fractions recognized only antigenic determinants present on those rat antibodies that had been used for the immunizations.
To show that the anti-idiotypic antibodies were indeed directed against the idiotopes of the rat Fab fragments we subjected mixtures containing labeled Fab fragments, antiidiotypic IgG fractions, and varying concentrations of RBP and insulin to indirect immunoprecipitation. RBP but not insulin abolished the interaction between the anti-RBP Fab fragments and the anti-idiotypic antibodies in a concentration-dependent manner. The binding of the Fab fragments against insulin to the anti-idiotypic IgG fractions was completely inhibited by insulin, whereas RBP had no effect on the interaction. Thus, it seems reasonable to conclude that the anti-idiotypic antibodies displayed reactivity only against the antigen-binding sites of theFab fragments.
Anti Fig. 1 ) we investigated the influence of the anti-idiotypic antibodies on the RBP-mediated uptake of retinol by the intestine epithelial cells. Fig. 4 shows that the anti-idiotypic IgG fraction impeded the RBP-mediated uptake of [3H]retinol by the cells. When the anti-idiotypic IgG fraction was passed over 6 E . . an immunosorbent column containing antibodies against RBP, the IgG in the breakthrough fraction did not exhibit the blocking effect (Fig. 4) , suggesting that it was indeed the anti-idiotypic antibodies against the antibodies to RBP that competed with RBP for binding to the receptor. This interpretation was further reinforced by the observation that when the antiidiotypic IgG fraction was passed over an immunosorbent column containing antibodies against #2-microglobulin, all of the inhibiting activity was recovered in the breakthrough fraction. Likewise, any type of antibodies will not impede the RBP-mediated uptake of [3H]retinol, as shown by the fact that antibodies against (02-microglobulin had no measurable effect on uptake of [3H]retinol by the cells. Thus, these data are consistent with the view that an anti-idiotypic antiserum raised against antibodies to RBP may contain some antibodies that recognize the RBP raceptor on the surface of intestine epithelial cells.
Anti-Idiotypic Antibodies against Antibodies to Insulin Bind to a Cell-Membrane Insulin Receptor. To examine if the anti-idiotypic antiserum raised against highly purified antibodies against insulin contained antibodies that recognized the cell-membrane insulin receptor we performed competition experiments with insulin and the anti-idiotypic IgG fractions. Thus, the binding of 125'-labeled insulin to fat cells was measured in the presence of IgG isolated from the anti-idiotypic antiserum. Fig. 5 shows that the IgG fraction inhibited the binding of the labeled insulin. No such inhibition was noted when IgG from the anti-idiotypic antiserum raised against antibodies to RBP was used. The figure also shows that the inhibiting activity in the IgG fraction from the anti-idiotypic antiserum raised against antibodies to insulin could be eliminated by passing the IgG fraction over an immunosorbent column containing antibodies to insulin, but no such effect was obtained with a column containing antibodies to RBP. This observation makes it reasonable to conclude that the anti-idiotypic antiserum raised against antibodies to insulin contained some antibodies that crossreacted with the insulin receptor on the rat epididymal fat cell membrane.
Anti-Idiotypic Antibodies against Antibodies to Insulin Mimic Insulin in Their Effect on Thymocyte AIB Uptake. From the reasoning detailed in Fig. 1 it is evident that antiidiotypic antibodies, if able to bind to the cell-surface receptor The anti-idiotypic IgG fraction against antibodies to insulin (0) was passed over immunosorbent columns containing antibodies to insulin (-) and to RBP (a), respectively. The breakthrough fractions from the columns were used in the experiment. An IgG fraction from the anti-idiotypic antiserum against antibodies to RBP served as the control (v).
A, should interact with the receptor in a ligand-like fashion. Thus, anti-idiotypic antibodies binding to the insulin receptor should interact with the insulin-binding domain of the receptor. If so, it is conceivable that the anti-idiotypic antibodies may exert an insulin-like effect on the cells. To test this possibility we examined AIB uptake by young rat thymocytes, which is stimulated by insulin (15) , in the presence of the anti-idiotypic antibodies. Fig. 6 shows that IgG fractions of anti-idiotypic antisera from two separate rabbits increased the AIB uptake to the same extent as insulin, although the amounts of protein required for the stimulation differed by several magnitudes. Normal IgG or IgG from an antiserum directed against the AgB antigens had no effect or depressed the AIB uptake by the thymocytes. The stimulating activity in the IgG fractions from the anti-idiotypic antisera was removed by immunosorbent chromatography of the IgG fractions on a Sepharose 4B column containing covalently bound antibodies to insulin. The IgG fractions from the anti-idiotypic antisera retained, however, full stimulating activity in the AIB uptake assay after they had been passed over In considering the specificity of the anti-idiotypic antibodies it may appear astonishing that antibodies are produced against self-structures (i.e., cell-surface receptors). However, it has been well documented in other experimental systems that tolerance may be abrogated by the immunization with modified selfstructures (see ref. 19 ). The "receptor-like" primary antibodies may, thus, be regarded as modified antigens. Once anti-idiotypic antibody-forming clones are activated, the cell-surface receptors may serve as the antigen so that an auto-immune reaction is induced. The present data do not provide any insight into this possibility, but it is tempting to suggest that this may be one of the mechanisms explaining the occurrence of antibodies to the insulin receptor in some diabetic patients (20) . Moreover, antibodies that are directed against a cell-surface receptor exerting a hormone-like action are frequently encountered in thyreotoxicosis. The long-acting thyroid stimulator may, thus, in some cases perhaps arise as an anti-idiotypic antibody. In the immune system per se it has been shown that autogeneously produced antibodies to receptors can be functional in regulating immunity of the individual producing the antibodies to the receptor (21) .
The present data suggest that the use of anti-idiotypic antibodies to explore the structure and function of cell-surface re--l-. 
